Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lasagna

Showing results (131-140 of 199) with videos related to

Pageof 20
Sort By:
Clinical Pharmacology and Therapeutics|March 1, 1988
New drug development in the United States, 1963 through 1984N Mattison, A G Trimble, L Lasagna
Clinical Pharmacology and Therapeutics|April 1, 1985
New drug applications: how long to gain approval?R N Spivey, L Lasagna, A G Trimble
Clinical Pharmacology and Therapeutics|January 1, 1971
A study of hospital staff attitudes concerning the comparative merits of antibioticsP V Macaraeg, L Lasagna, J R Bianchine
JAMA|February 25, 1974
Variations in interpretation of prescription instructions. The need for improved prescribing habitsJ M Mazzullo, L Lasagna, P F Griner
Clinical Pharmacology and Therapeutics|June 1, 1983
New drug development during and after a period of regulatory change: clinical research activity of major United States pharmaceutical firms, 1958 to 1979M S May, W M Wardell, L Lasagna
Journal of Clinical Pharmacology|May 1, 1993
The role of the research-based pharmaceutical industry in medical progress in the United StatesK I Kaitin, N R Bryant, L Lasagna
Clinical Pharmacology and Therapeutics|May 1, 1984
Drug discontinuations in the United Kingdom and the United States, 1964 to 1983: issues of safetyO M Bakke, W M Wardell, L Lasagna
Journal of Clinical Pharmacology|August 1, 1987
Trends in drug development: the 1985-86 new drug approvalsK I Kaitin, B W Richard, L Lasagna
Clinical Pharmacology and Therapeutics|June 1, 1994
New drug development in the United States from 1963 to 1992J A DiMasi, M A Seibring, L Lasagna
Clinical Pharmacology and Therapeutics|November 1, 1991
New drug development in the United States from 1963 to 1990J A DiMasi, N R Bryant, L Lasagna
Pageof 20

Showing results (131-140 of 199) with videos related to

Sort By:
Pageof 20
Clinical Pharmacology and Therapeutics|March 1, 1988
New drug development in the United States, 1963 through 1984N Mattison, A G Trimble, L Lasagna
Clinical Pharmacology and Therapeutics|April 1, 1985
New drug applications: how long to gain approval?R N Spivey, L Lasagna, A G Trimble
Clinical Pharmacology and Therapeutics|January 1, 1971
A study of hospital staff attitudes concerning the comparative merits of antibioticsP V Macaraeg, L Lasagna, J R Bianchine
JAMA|February 25, 1974
Variations in interpretation of prescription instructions. The need for improved prescribing habitsJ M Mazzullo, L Lasagna, P F Griner
Clinical Pharmacology and Therapeutics|June 1, 1983
New drug development during and after a period of regulatory change: clinical research activity of major United States pharmaceutical firms, 1958 to 1979M S May, W M Wardell, L Lasagna
Journal of Clinical Pharmacology|May 1, 1993
The role of the research-based pharmaceutical industry in medical progress in the United StatesK I Kaitin, N R Bryant, L Lasagna
Clinical Pharmacology and Therapeutics|May 1, 1984
Drug discontinuations in the United Kingdom and the United States, 1964 to 1983: issues of safetyO M Bakke, W M Wardell, L Lasagna
Journal of Clinical Pharmacology|August 1, 1987
Trends in drug development: the 1985-86 new drug approvalsK I Kaitin, B W Richard, L Lasagna
Clinical Pharmacology and Therapeutics|June 1, 1994
New drug development in the United States from 1963 to 1992J A DiMasi, M A Seibring, L Lasagna
Clinical Pharmacology and Therapeutics|November 1, 1991
New drug development in the United States from 1963 to 1990J A DiMasi, N R Bryant, L Lasagna
Pageof 20